The shift to value-based care, concurrent with innovations in immune-based care, will create challenges in oncology. What should be the physician and manufacturer responsibility during these changing times?
Diana Verrilli
Advertisement
Articles by Diana Verrilli
The Wilshire Oncology Medical Group developed a medical oncology home pilot to offer a transparent, high-quality, high-value cancer program in partnership with its largest California health plan, Anthem Blue Cross WellPoint.
Advertisement
Latest Updated Articles
- Advanced APMs and the Emerging Role of Immuno-Oncology Agents: Balancing Innovation and Value
Published: February 16th 2017 | Updated:
- Partnering With a Payer to Develop a Value-Based Medical Home Pilot: A West Coast Practice's Experience
Published: May 10th 2012 | Updated:
- Partnering With a Payer to Develop a Value-Based Medical Home Pilot: A West Coast Practice's Experience
Published: September 20th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Raludotatug Deruxtecan Demonstrates Promising Efficacy, Safety in Platinum-Resistant Ovarian Cancer
3
Navigating Costs and Logistics of Cellular Therapies, ADCs, and Novel Diagnostics in Cancer Care
4
Team-Based Precision Oncology: Advancing Value and Access in Cancer Care
5
